PURPOSE: To evaluate the safety and efficacy of intravitreal triamcinolone after 18 months of follow up in patients with age-related macular degeneration and subfoveal or juxtafoveal choroidal neovascularization considered unsuitable for laser photocoagulation. METHODS: Thirty eyes of 28 patients, referred from general eye clinics as well as the private clinic of one of the authors…
Australian and New Zealand Journal of Ophthalmology Template
Write in a clean editor, then format for Australian and New Zealand Journal of Ophthalmology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Australian and New Zealand Journal of Ophthalmology format
Australian and New Zealand Journal of Ophthalmology is a peer-reviewed journal published by Wiley, covering Glaucoma and retinal disorders, Intraocular Surgery and Lenses, Corneal surgery and disorders.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Australian and New Zealand Journal of Ophthalmology 12 (3): 45–58.
Formats any DOI in Australian and New Zealand Journal of Ophthalmology style. No sign-up. |
| Publishes research in | Glaucoma and retinal disorders Intraocular Surgery and Lenses Corneal surgery and disorders Retinal Diseases and Treatments Ophthalmology and Eye Disorders |
| ISSN | 0814-9763 |
| h-index | 52 |
| i10-index | 572 |
| Total citations | 19,450 |
| Top institutions publishing here | The Royal Victorian Eye & Ear Hospital |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Australian and New Zealand Journal of Ophthalmology per year
Citation impact of Australian and New Zealand Journal of Ophthalmology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Australian and New Zealand Journal of Ophthalmology
Ocular trauma is the cause of blindness in approximately half a million people worldwide, and many more have suffered partial loss of sight. Trauma is often the most important cause of unilateral loss of vision, particularly in developing countries. There is a cumulative risk of ocular trauma and visual loss during life, but the true…
PURPOSE: To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise. METHODS: A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied. RESULTS: Approximately 30% of the study group…
This study is based on the clinico-pathological examination of 512 eyes. As senile macular degeneration developed drusen appeared to alter in consistency and become more fluid. This resulted in a spectrum of clinical appearances classified as hard, semisolid, soft or serous, and regressing. Histologically the hyaline contents of the drusen changed to a pale-staining amorphous…
PURPOSE: To study the efficacy of the anti-inflammatory agent triamcinolone (Kenacort A-40) in patients with exudative age-related macular degeneration and subfoveal and juxtafoveal choroidal new vessels, considered unsuitable for laser photocoagulation. METHOD: Thirty eyes of 28 patients were treated with intravitreal injection of triamcinolone. The subsequent visual acuity (VA) of treated eyes was compared with…